RFX1 and esophageal adenocarcinoma: Our approach revealed that Rfx1 expression decreases gradually during cellular progression to esophageal adenocarcinoma, indicating that mechanistic and clinically useful insights can emerge from studies of transcription factors bound to silent genes.